Published in J Immunol on July 01, 1996
Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinase. Mol Cell Biol (1999) 1.01
Oncogenic Signaling by Leukemia-Associated Mutant Cbl Proteins. Biochem Anal Biochem (2012) 0.85
SRC Homology 2 Domain Binding Sites in Insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome. Cell Commun Signal (2012) 0.82
The adaptor protein Crk in immune response. Immunol Cell Biol (2013) 0.81
CBL linker region and RING finger mutations lead to enhanced granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling via elevated levels of JAK2 and LYN. J Biol Chem (2013) 0.79
The Role of Crk Adaptor Proteins in T-Cell Adhesion and Migration. Front Immunol (2015) 0.75
SH2 domains recognize specific phosphopeptide sequences. Cell (1993) 17.28
Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry (1994) 13.94
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (2001) 11.56
Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc Natl Acad Sci U S A (1982) 7.16
Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J (1992) 5.84
Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell (1993) 5.47
Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol (1994) 5.02
Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. J Exp Med (1983) 4.92
Prevention of fat-induced insulin resistance by salicylate. J Clin Invest (2001) 4.74
The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J Immunol (1983) 4.17
Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature (1983) 4.16
Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell (1998) 3.84
Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci U S A (1990) 3.70
Crystal structure of the tyrosine phosphatase SHP-2. Cell (1998) 3.48
Headaches and sinus disease: the endoscopic approach. Ann Otol Rhinol Laryngol Suppl (1988) 3.45
Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol (1984) 3.26
A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J Biol Chem (1997) 3.19
Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck. Nature (1993) 3.14
Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A (1992) 2.98
A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. J Biol Chem (1988) 2.90
Selective targeting of somatostatin receptor 3 to neuronal cilia. Neuroscience (1999) 2.84
Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature (1999) 2.82
Molecular cloning of a 25-kDa high affinity rapamycin binding protein, FKBP25. J Biol Chem (1992) 2.76
Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography. Radiology (1997) 2.67
Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature (1995) 2.59
Monoallelic expression of the interleukin-2 locus. Science (1998) 2.58
Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association. Am J Surg Pathol (2001) 2.55
Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature (1985) 2.51
Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. Proc Natl Acad Sci U S A (1982) 2.51
Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts. Mol Cell Biol (1993) 2.47
Expression and function of CD4 in a murine T-cell hybridoma. Nature (1987) 2.46
Skin island flaps supplied by the vascular axis of the sensitive superficial nerves: anatomic study and clinical experience in the leg. Plast Reconstr Surg (1992) 2.39
Essential role for Gab2 in the allergic response. Nature (2001) 2.32
Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. Proc Natl Acad Sci U S A (1994) 2.31
Dileucine-based sorting signals bind to the beta chain of AP-1 at a site distinct and regulated differently from the tyrosine-based motif-binding site. EMBO J (1998) 2.27
Interaction of Shc with the zeta chain of the T cell receptor upon T cell activation. Science (1993) 2.25
Inhibition of cell-mediated cytolysis of trinitrophenyl-derivatized target cells by alloantisera directed to the products of the K and D loci of the H-2 complex. Proc Natl Acad Sci U S A (1976) 2.20
The biologic significance of alloreactivity. The ontogeny of T-cell sets specific for alloantigens or modified self antigens. J Exp Med (1978) 2.20
B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol (1988) 2.20
Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor. J Biol Chem (1993) 2.13
The role of L3T4 in recognition of Ia by a cytotoxic, H-2Dd-specific T cell hybridoma. J Exp Med (1984) 2.13
The biologic roles of CD2, CD4, and CD8 in T-cell activation. Annu Rev Immunol (1989) 2.13
Severe colitis in mice with aberrant thymic selection. Immunity (1995) 2.11
Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Mol Cell (1998) 2.11
Palliative fetal surgery for diaphragmatic hernia. Am J Obstet Gynecol (1994) 2.05
Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest (1994) 1.99
T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc Natl Acad Sci U S A (1994) 1.95
Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell (1996) 1.92
Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res (1997) 1.89
Phytohaemagglutinin activation of T cells through the sheep red blood cell receptor. Nature (1985) 1.89
Determination of junction avidity of cytolytic T cell and target cell. Science (1986) 1.88
Probing immunosuppressant action with a nonnatural immunophilin ligand. Science (1990) 1.88
The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70. J Biol Chem (1997) 1.87
Specificity of OKT4+ cytotoxic T lymphocyte clones. J Immunol (1982) 1.84
Immunophilins in protein folding and immunosuppression. FASEB J (1994) 1.80
SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange. Mol Cell Biol (1993) 1.77
Structure of the regulatory domains of the Src-family tyrosine kinase Lck. Nature (1994) 1.77
Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals. Kidney Int (1998) 1.75
Human cytolytic T lymphocyte interactions with vascular endothelium and fibroblasts: role of effector and target cell molecules. J Immunol (1984) 1.75
Cross-reactive lysis of trinitrophenyl (TNP)-derivatized H-2 incompatible target cells by cytolytic T lymphocytes generated against syngeneic TNP spleen cells. J Exp Med (1976) 1.74
Allospecific and virus-specific cytolytic T lymphocytes are restricted to the N or C1 domain of H-2 antigens expressed on L cells after DNA-mediated gene transfer. Proc Natl Acad Sci U S A (1983) 1.74
LFA-1, LFA-2, and LFA-3 antigens are involved in CTL-target conjugation. J Immunol (1984) 1.72
Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes. Nature (1995) 1.71
RNA binding fragments from nucleolin contain the ribonucleoprotein consensus sequence. J Biol Chem (1987) 1.69
Receptor binding redefined by a structural switch in a mutant human insulin. Nature (1991) 1.68
Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. J Biol Chem (1995) 1.66
Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2. Nature (1996) 1.65
Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation. J Biol Chem (2000) 1.63
Constitutively active Pto induces a Prf-dependent hypersensitive response in the absence of avrPto. EMBO J (1999) 1.62
Rapid development of severe end-organ damage in C57BL/6 mice by combining DOCA salt and angiotensin II. Kidney Int (2007) 1.62
Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation. J Exp Med (1987) 1.61
CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature (1991) 1.60
Multiple functions of vitamin A. Physiol Rev (1984) 1.58
Molecular cloning of a membrane-associated human FK506- and rapamycin-binding protein, FKBP-13. Proc Natl Acad Sci U S A (1991) 1.58
Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells. Proc Natl Acad Sci U S A (1978) 1.58
Construction, expression and recognition of an H-2 molecule lacking its carboxyl terminus. Nature (1984) 1.57
Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia. Neuroscience (2004) 1.57
Adhesion of T lymphocytes to human endothelial cells is regulated by the LFA-1 membrane molecule. J Cell Physiol (1986) 1.57
CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J Exp Med (1995) 1.54
Crystal structure of human frataxin. J Biol Chem (2000) 1.54
Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro. J Biol Chem (1992) 1.52
Preimplantation diagnosis of single gene disorders by two-step oocyte genetic analysis using first and second polar body. Biochem Mol Med (1997) 1.52
Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. J Immunol (1985) 1.52
Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. J Immunol (1988) 1.51
Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene. Proc Natl Acad Sci U S A (1979) 1.50
Expression of the T-cell surface molecule CD2 and an epitope-loss CD2 mutant to define the role of lymphocyte function-associated antigen 3 (LFA-3) in T-cell activation. Proc Natl Acad Sci U S A (1988) 1.49
Dissection of serological and cytolytic T lymphocyte epitopes on murine major histocompatibility antigens by a recombinant H-2 gene separating the first two external domains. J Exp Med (1984) 1.48
Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide. Cell (1994) 1.48
Sacral neuromodulation in functional urinary retention: an effective way to restore voiding. BJU Int (2002) 1.47
Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1. J Biol Chem (1994) 1.46
Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood (2001) 1.46
Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes. Nat Struct Biol (1996) 1.46
Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor. J Exp Med (1988) 1.45
Cyclooxygenase metabolites mediate glomerular monocyte chemoattractant protein-1 formation and monocyte recruitment in experimental glomerulonephritis. Kidney Int (1999) 1.45
Tandem SH2 domains confer high specificity in tyrosine kinase signaling. J Biol Chem (1998) 1.45
Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer (1997) 1.44
Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett (2001) 1.44
Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J Biol Chem (1994) 1.43
The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation. J Biol Chem (1994) 1.43